Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Current Atherosclerosis Reports|May 18, 2011
Antithrombotic management for transient ischemic attack and ischemic stroke (other than atrial fibrillation)J Donald EastonCerebrovascular Diseases (Basel, Switzerland)|April 17, 2003
Evidence with antiplatelet therapy and ADP-receptor antagonistsJ Donald EastonJournal of the National Medical Association|April 24, 2004
Stroke Best Practices: a team approach to evidence-based careMark J Alberts, J Donald EastonInternational Journal of Stroke : Official Journal of the International Stroke Society|February 7, 2019
New opportunities to optimize antithrombotic therapy for secondary stroke preventionAnthony S Kim, J Donald EastonStroke|September 6, 2003
Are patients with acutely recovered cerebral ischemia more unstable?S Claiborne Johnston, J Donald EastonExpert Opinion on Pharmacotherapy|August 29, 2018
Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary strokeHans-Christoph Diener, George Ntaios, Martin O'Donnell, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 2, 2024
Time to treatment and disability attributed to index stroke in the POINT trialPargol Balali, J Donald Easton, S Claiborne Johnston, et al.Neurology|September 21, 2012
Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillationHooman Kamel, J Donald Easton, S Claiborne Johnston, et al.Stroke|January 4, 2024
Baseline Stroke Risk and Efficacy of Dual-Antiplatelet Therapy: A Post Hoc Analysis of the POINT TrialIyas Daghlas, S Claiborne Johnston, J Donald Easton, et al.Stroke|February 7, 2012
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attackHooman Kamel, S Claiborne Johnston, J Donald Easton, et al.Pageof 8